HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Debabrata Saha Selected Research
Debabrata Saha Research Topics
Disease
43
Neoplasms (Cancer)
01/2022 - 08/2002
11
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 08/2003
9
Prostatic Neoplasms (Prostate Cancer)
11/2019 - 04/2010
8
Lung Neoplasms (Lung Cancer)
10/2020 - 01/2003
6
Hypoxia (Hypoxemia)
01/2022 - 04/2009
5
Carcinoma (Carcinomatosis)
01/2011 - 08/2003
4
Glioblastoma (Glioblastoma Multiforme)
12/2021 - 05/2007
4
Neoplasm Metastasis (Metastasis)
11/2019 - 07/2014
3
Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2019
3
Carcinogenesis
01/2019 - 10/2010
3
Rectal Neoplasms (Rectal Cancer)
04/2011 - 07/2009
2
Head and Neck Neoplasms (Head and Neck Cancer)
12/2021 - 01/2019
2
Colonic Neoplasms (Colon Cancer)
01/2019 - 04/2011
2
Chromosomal Instability (Chromosome Stability)
10/2016 - 04/2015
2
Inflammation (Inflammations)
04/2013 - 08/2008
2
Extranodal Extension
01/2011 - 01/2007
2
Brain Neoplasms (Brain Tumor)
08/2003 - 01/2003
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2003 - 01/2003
1
Glioma (Gliomas)
12/2021
1
Mucositis
12/2021
1
Adenocarcinoma
12/2021
1
Ataxia Telangiectasia (Louis Bar Syndrome)
07/2014
1
Chronic Hepatitis C
02/2014
1
Venous Thrombosis (Deep-Vein Thrombosis)
02/2014
1
Unilateral Breast Neoplasms
02/2014
1
Pleural Effusion (Pleural Effusions)
04/2013
1
Asthma (Bronchial Asthma)
04/2013
1
Osteosarcoma (Osteogenic Sarcoma)
04/2013
Drug/Important Bio-Agent (IBA)
7
DNA (Deoxyribonucleic Acid)
IBA
01/2017 - 01/2008
6
Proteins (Proteins, Gene)
FDA Link
07/2014 - 08/2008
4
Pharmaceutical Preparations
IBA
12/2021 - 09/2003
4
Radiation-Sensitizing Agents
IBA
05/2015 - 09/2003
4
N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamide
IBA
10/2009 - 02/2006
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 04/2013
3
8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- one
IBA
10/2017 - 02/2015
3
Biological Products
IBA
01/2016 - 07/2010
3
Luciferases
IBA
11/2014 - 04/2011
3
Prostaglandins
IBA
02/2006 - 07/2002
3
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
02/2006 - 07/2002
2
Oxygen (Dioxygen)
IBA
01/2022 - 06/2017
2
Ions
IBA
01/2022 - 10/2010
2
Crizotinib
IBA
12/2021 - 03/2013
2
Glutathione (Reduced Glutathione)
IBA
12/2021 - 10/2020
2
Polylactic Acid-Polyglycolic Acid Copolymer
IBA
10/2017 - 05/2015
2
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
10/2016 - 05/2013
2
lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)
IBA
04/2015 - 12/2012
2
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
07/2014 - 04/2010
2
Tamoxifen
FDA Link
Generic
02/2014 - 07/2009
2
epothilone B (EPO906)
IBA
11/2010 - 09/2003
2
Cyclin-Dependent Kinases (cdk Proteins)
IBA
10/2009 - 02/2006
2
2-aminothiazole
IBA
04/2009 - 05/2007
2
NF-kappa B (NF-kB)
IBA
04/2009 - 08/2008
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2009 - 05/2007
2
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
08/2003 - 01/2003
1
Thioredoxins
IBA
12/2021
1
Superoxides (Superoxide)
IBA
12/2021
1
Superoxide Dismutase
IBA
12/2021
1
Catalase
IBA
12/2021
1
Neutralizing Antibodies
IBA
12/2021
1
Buthionine Sulfoximine
IBA
12/2021
1
avasopasem manganese
IBA
12/2021
1
navitoclax
IBA
12/2021
1
Auranofin (Ridaura)
FDA Link
12/2021
1
Hydrogen Peroxide (Hydroperoxide)
FDA Link
Generic
12/2021
1
DEAE-Dextran (Pulsar)
IBA
01/2021
1
Stimuli Responsive Polymers
IBA
10/2020
1
Polyurethanes (Polyurethane)
IBA
10/2020
1
Disulfides
IBA
10/2020
1
Cisplatin (Platino)
FDA Link
Generic
10/2020
1
Caveolin 1
IBA
11/2019
1
Dichlorodiphenyldichloroethane (DDD)
IBA
11/2019
1
MicroRNAs (MicroRNA)
IBA
01/2019
1
Messenger RNA (mRNA)
IBA
01/2019
1
Replication Protein A
IBA
11/2017
1
Cetuximab (Erbitux)
FDA Link
11/2017
1
carboxymethyl-chitosan
IBA
10/2017
1
Folic Acid (Vitamin M)
FDA Link
Generic
10/2017
1
poly-N-isopropylacrylamide
IBA
10/2017
1
Gemcitabine
FDA Link
10/2017
1
Androgens
IBA
12/2015
1
10- (2- hydroxypropyl)- 1,4,7- tetraazacyclododecane- 1,4,7- triacetic acid
IBA
11/2015
1
Ligands
IBA
11/2015
1
Nitroimidazoles
IBA
11/2015
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2014
1
cytolethal distending toxin
IBA
07/2014
1
Prostate-Specific Antigen (Semenogelase)
IBA
07/2014
1
Enhancer of Zeste Homolog 2 Protein
IBA
07/2014
1
L 644711 (B-3(+))
IBA
04/2013
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
03/2013
Therapy/Procedure
20
Radiotherapy
01/2022 - 01/2003
11
Therapeutics
12/2021 - 01/2003
8
Drug Therapy (Chemotherapy)
01/2022 - 01/2003
3
Castration
11/2019 - 07/2014
1
Immunotherapy
01/2021
1
Injections
10/2020
1
Segmental Mastectomy (Lumpectomy)
02/2014
1
Aftercare (After-Treatment)
05/2013
1
Image-Guided Radiotherapy
05/2013
1
Combined Modality Therapy
05/2013
1
Surgical Amputation (Amputations)
04/2013